Memorial Sloan Kettering Pediatric Oncologist Sameer Farouk Sait

Sameer Farouk Sait, MBBS

Pediatric Hematologist-Oncologist

My Role at MSK

Areas of Expertise

My Specialties

  • Pediatric Brain and Spinal Cord Tumors, Neurofibromatosis Type 1 and Rasopathies, Adolescent and Young Adult Oncology, Molecular Targeted Therapies and Combinations with Immunotherapies, Radio-Immunotherapy

Request an Appointment

Our Care Advisors can answer many of your questions. They will connect you with the best healthcare provider for your needs.
Share

About Me

What I Do at MSK
  • Instructor
Get To Know Me

I am a pediatric oncologist on the MSK Kids team who specializes in the treatment of pediatric brain tumors, including low-grade and high-grade gliomas, embryonal tumors like medulloblastoma, and ependymoma. I have a special interest in treating adolescents and young adults with these cancers. I also care for patients with neurofibromatosis type 1 (NF1) and its associated cancer-related conditions — including plexiform neurofibromas, malignant peripheral nerve sheath tumors (MPNSTs), and high-grade gliomas — as well as non-cancer-related issues. At Memorial Sloan Kettering Cancer Center (MSK), I work with a multidisciplinary team to offer comprehensive care, which is critical for patients with NF1.

Read more

In my research, I explore the molecular drivers of brain tumors, with the goal of identifying new targets that can be used to develop innovative targeted therapies. My colleagues and I look at how using different anti-cancer drugs individually and in combination affects tumor growth and resistance to therapy, including the influence of immature cells called stem cells. We also study the use of radioimmunotherapy (radiation therapy given with immunotherapy to precisely target brain cancer cells while sparing nearby normal healthy tissues).

I work closely with the Brain Tumor Center, led by developmental biologist Luis Parada at the Sloan Kettering Institute, to conduct translational research to identify more effective combination treatments for children and adults with NF1 high-grade gliomas and MPNSTs. I am also a member of the Pediatric Translational Medicine Program. Our shared goal is to take findings from laboratory studies, translate them into early-phase clinical trials for young patients, and improve these patients’ quality of their care. I enjoy being able to conduct research at MSK, where there are excellent resources for investigators like myself, while caring for patients. It provides an opportunity to make a difference and improve the lives of these young patients.

Beyond these research endeavors, I also collaborate with the team in the MSK Kids Clinical Genetics Service and Pediatric Cancer Predisposition Screening Program. Here, patients and families benefit from genetic counseling and testing for cancer predisposition syndromes like NF1. We’re starting to perform more sophisticated molecular testing in patients, such as testing for DNA fragments shed in the blood (circulating cell-free DNA), to not only detect cancer but also to understand why some people develop cancer. This may eventually lead to prevention, earlier intervention, and cures. There are also many exciting developments and specific drug treatments that have recently emerged for people with these cancer predisposition syndromes.

What I find most gratifying about my work is being able to apply the scientific knowledge I’ve acquired, offer patients innovative and less toxic treatments when feasible, and see these efforts benefit my patients. I was attracted to the field of pediatric neuro-oncology because I felt like there was a lot of room to improve the treatment that we use to care for patients with these cancers, especially given how prevalent they are in this patient population. Brain tumors are the second most common form of cancer in children, after leukemia.

When I meet an adolescent or young adult with cancer, I individualize the experience for them and try to make them feel empowered. Just as each person’s cancer has different or distinctive genetic changes, every person I care for is also unique. Beyond personalized care, it is also important to me to give patients the opportunity to express their concerns and ask any questions that they may have so I can alleviate their anxieties.

Cancer care for this age group is sometimes fragmented. Whereas some patients receive care from MSK’s pediatric oncologists, others will work with our medical oncologists. We have a special program here at MSK to ensure that patients in this age group receive seamless care.

My Role at MSK

A pediatric hematologist-oncologist is a doctor who treats cancers of the blood in children and adolescents. This doctor is a hematologist (HEE-muh-TAH-loh-jist) who diagnoses and treats blood disorders. They also are an oncologist (cancer doctor).

Areas of Expertise

My Specialties

  • Pediatric Brain and Spinal Cord Tumors, Neurofibromatosis Type 1 and Rasopathies, Adolescent and Young Adult Oncology, Molecular Targeted Therapies and Combinations with Immunotherapies, Radio-Immunotherapy
Education & Honors

Education

  • MBBS, Kasturba Medical College (2004-2010)

Residencies

  • General Pediatrics - Saint Peter’s University Hospital (2012-2015)

Awards and Honors

  • K12 Paul Calabrese Career Development Award in Clinical Oncology – Research Scholar (2018-2021)
  • Career Development Award – Developmental and Hyperactive RAS Tumor SPORE (2015-2021)
  • Matthew Larson Foundation grant for Pediatric Brain Tumors (2022-2023)

Fellowships

  • Pediatric Hematology/Oncology - Memorial Sloan Kettering Cancer Center (2015-2018)

Board Certifications

  • American Board of Pediatrics - American Board of Pediatric Hematology/Oncology

Insurance Information

Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.

Aetna

In Network Coverage Type
HMO, EPO PPO, POS, Transplant

Aetna Medicare Advantage (City of NY retirees only, starting 9/1/23)

In Network Coverage Type
PPO

Blue Cross Blue Shield Federal Employee Program

In Network Coverage Type
HMO, PPO

Blue Cross Blue Shield New York

In Network Coverage Type
PPO, POS, EPO, HMO

Blue Cross Blue Shield states outside of NY/NJ

In Network Coverage Type
HMO, EPO PPO, POS

Blue Cross Health Plus

In Network Coverage Type
HMO

Carrum Health

In Network Coverage Type
Supplemental

Cigna

In Network Coverage Type
PPO, POS, HMO

Connecticare

In Network Coverage Type
POS, EPO, HMO

Emblem

In Network Coverage Type
PPO, POS, EPO, HMO

Emblem Essential

In Network Coverage Type
HMO

Emblem Medicare Advantage

In Network Coverage Type
PPO, HMO

Empire Blue Cross Medicare Advantage

In Network Coverage Type
PPO, HMO, DSN

Empire Essential

In Network Coverage Type
HMO

Empire Plan / NYSHIP (Blue Cross/UnitedHealthcare split plan)

In Network Coverage Type
PPO

Fidelis

In Network Coverage Type
HMO, EPO

Fidelis Managed Medicaid & HARP

In Network Coverage Type
HMO

Fidelis Medicare Advantage

In Network Coverage Type
HMO

First Health

In Network Coverage Type
PPO

Healthfirst

In Network Coverage Type
EPO, HMO, PPO, POS

Healthfirst Managed Medicaid

In Network Coverage Type
HMO

Healthfirst Medicare Advantage

In Network Coverage Type
HMO, PPO

Healthsmart

In Network Coverage Type
PPO EPO

Horizon Blue Cross Blue Shield New Jersey (HMO)

In Network Coverage Type
HMO

Horizon Blue Cross Blue Shield New Jersey (PPO)

In Network Coverage Type
PPO

Horizon Blue Cross Blue Shield New Jersey Omnia Tier I (EPO)

In Network Coverage Type
EPO

Horizon Blue Cross Blue Shield New Jersey Omnia Tier II (EPO)

In Network Coverage Type
EPO

Horizon Medicare Advantage

In Network Coverage Type
PPO, HMO

Husky CT Medicaid

In Network Coverage Type
State Government

Magnacare

In Network Coverage Type
PPO, POS, EPO

Straight NJ Medicaid

In Network Coverage Type
State Government

Straight NY Medicaid

In Network Coverage Type
State Government

Medicare Part A&B (traditional Medicare)

In Network Coverage Type
Federal Government

Multiplan/Beech Street/PHCS

In Network Coverage Type
Supplemental

MVP

In Network Coverage Type
PPO/OAP

Non-Participating Plans with Out of Network Benefits

In Network Coverage Type
PPO, POS, EPO, HMO

NYC Medicare Advantage Plus for City Employees

In Network Coverage Type
TBD

Oscar

In Network Coverage Type
HMO/EPO

Oxford

In Network Coverage Type
PPO, EPO

World Trade Center Health Program (WTC)

In Network Coverage Type
State Government

Qualcare

In Network Coverage Type
PPO, POS, HMO

Tricare

In Network Coverage Type
PPO, HMO

UMR

In Network Coverage Type
PPO, POS

United Healthcare

In Network Coverage Type
PPO, POS, HMO

Don't see your carrier or plan? We can help you understand your coverage.

If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.

If you have questions about insurance, call us at 646-497-9176.

Make an Appointment

Current Patients

Request an appointment by logging on to MyMSK or calling your doctor’s office. If you aren’t registered for MyMSK, call 646-227-2593 for your Enrollment ID.

Contact and Location

Dr. Sait sees patients at one location.

Office Phone
Location
New York, NY
1275 York Avenue New York NY 10065

Looking to see a doctor at a different location? See all MSK locations.

Colleagues

Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

See all Pediatrics doctors

Clinical Trials

Read more
Smiling doctors in the lab
Find a Clinical Trial for You

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.

You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.

Search clinical trials

Research and Publications

Publications on PubMed

Visit PubMed for a full listing of Dr. Sait’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.

See all on PubMed

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Sameer Farouk Sait discloses the following relationships and financial interests:

  • AstraZeneca
    Professional Services and Activities
  • QED Therapeutics, Inc.
    Professional Services and Activities (Uncompensated)

If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.

The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.


This page and data include information for a specific MSK annual disclosure period (January 1, 2022 through disclosure submission in spring 2023). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures